167 related articles for article (PubMed ID: 33624292)
21. Review of investigative diagnostic techniques for cutaneous lymphoma.
Slater DN
Semin Dermatol; 1994 Sep; 13(3):166-71. PubMed ID: 7986684
[TBL] [Abstract][Full Text] [Related]
22. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review.
Plumptre IR; Said JT; Sun T; Larocca C; Virgen CA; Kupper TS; Fisher DC; Devlin PM; Elco CP; Song JS; LeBoeuf NR
Leuk Lymphoma; 2022 Dec; 63(12):2832-2846. PubMed ID: 35862569
[TBL] [Abstract][Full Text] [Related]
23. Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders: A Clinical, Pathologic, and Molecular Study of 60 Cases Presenting With a Single Lesion: A Multicenter Study of the French Cutaneous Lymphoma Study Group.
Beltzung F; Ortonne N; Pelletier L; Beylot-Barry M; Ingen-Housz-Oro S; Franck F; Pereira B; Godfraind C; Delfau MH; D'Incan M; Vergier B
Am J Surg Pathol; 2020 Jul; 44(7):862-872. PubMed ID: 32271188
[TBL] [Abstract][Full Text] [Related]
24. Primary cutaneous CD4
Plumptre IR; Said JT; Sheu Song J; Corey K; LeBoeuf NR
Pediatr Blood Cancer; 2022 Sep; 69(9):e29862. PubMed ID: 35730956
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-Associated B-Cell Lymphoproliferative Disease in a Patient With Cutaneous T-Cell Lymphoma.
Maderal AD; Malone JC; Callen JP
JAMA Dermatol; 2018 Apr; 154(4):490-492. PubMed ID: 29490369
[No Abstract] [Full Text] [Related]
26. Primary cutaneous CD4+ small-to-medium-sized pleomorphic T-cell lymphoma: a rare case report of infant.
Li D; Guo B; Li D; Chang C; Lu Q
J Clin Pathol; 2015 Oct; 68(10):855-8. PubMed ID: 26112823
[No Abstract] [Full Text] [Related]
27. The development of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoproliferative disorder at the site of a melanoma excision scar.
Aria AB; Wilmas K; Kim EJ; Aung PP; Duvic M
Dermatol Online J; 2018 Sep; 24(9):. PubMed ID: 30677830
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoproliferative disorder: Where do we stand? A systematic review.
Salah E
J Dtsch Dermatol Ges; 2019 Feb; 17(2):123-136. PubMed ID: 30506921
[TBL] [Abstract][Full Text] [Related]
29. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
Magro CM; Olson LC; Fulmer CG
Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment.
Willemze R; Beljaards RC
J Am Acad Dermatol; 1993 Jun; 28(6):973-80. PubMed ID: 8388410
[TBL] [Abstract][Full Text] [Related]
31. Primary Cutaneous CD4+ Small/Medium-Sized T-Cell Lymphoma With Spontaneous Regression After Biopsy.
González Fernández D; Valdés Pineda F; Gómez Díez S; Vivanco Allende B
Actas Dermosifiliogr; 2015 Nov; 106(9):767-8. PubMed ID: 26093997
[No Abstract] [Full Text] [Related]
32. Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category.
Williams VL; Torres-Cabala CA; Duvic M
Am J Clin Dermatol; 2011 Dec; 12(6):389-401. PubMed ID: 21863906
[TBL] [Abstract][Full Text] [Related]
33. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
34. C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.
Geller S; Hollmann TJ; Horwitz SM; Myskowski PL; Pulitzer M
Histopathology; 2020 Jan; 76(2):222-232. PubMed ID: 31355940
[TBL] [Abstract][Full Text] [Related]
35. [Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: report of a case with spontaneous resolution].
Messeguer F; Gimeno E; Agusti-Mejias A; San Juan J
Actas Dermosifiliogr; 2011 Oct; 102(8):636-8. PubMed ID: 21605848
[No Abstract] [Full Text] [Related]
36. Early onset post-transplant lymphoproliferative disorder following cutaneous NK/T-cell lymphoma mimicking recurrence.
Wang SH; Medeiros LJ; Chen TY; Chang KC
Pathology; 2022 Oct; 54(6):807-809. PubMed ID: 35144827
[No Abstract] [Full Text] [Related]
37. How I treat primary cutaneous CD30
Shinohara MM; Shustov A
Blood; 2019 Aug; 134(6):515-524. PubMed ID: 31164331
[TBL] [Abstract][Full Text] [Related]
38. Differential NFATc1 Expression in Primary Cutaneous CD4+ Small/Medium-Sized Pleomorphic T-Cell Lymphoma and Other Forms of Cutaneous T-Cell Lymphoma and Pseudolymphoma.
Magro CM; Momtahen S
Am J Dermatopathol; 2017 Feb; 39(2):95-103. PubMed ID: 27097342
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous CD4 positive small/medium T cell lymphoma.
Jain G; Aiyer HM
Indian J Dermatol Venereol Leprol; 2018; 84(2):186-188. PubMed ID: 29363627
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
